Skip to main content
Caplight Logo









Incision

Incision

Private
AmsterdamHealthcare & Life Scienceshttps://www.incision.care/

Last Round

Series B

Nov 1, 2023

Total Funding Raised

$16.35M

Company Overview

Incision is a healthtech company that provides a digital platform for surgical performance, online training, and workflow optimization to help surgical teams improve efficiency and patient outcomes.

Sector

Healthcare & Life Sciences

Verticals

Vertical SaaS, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

surgical trainingsurgical educationsurgical e-learningmedtechsurgical procedure guidancevertical SaaSsurgical video libraryperioperative trainingsurgical simulationhealthcare SaaSOR efficiencysurgical workflowmedical education platformclinical training

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Incision Comparables

Compare Incision with similar companies based on industry and business-model similarity.

Incision comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ConvaTec Group PLC
75%
Medtronic
75%
Proximie
75%

Incision Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 1, 2023
Series AMay 27, 2021

Key People

Founding team and executive leadership

Jeff Perales

Chief Executive Officer, Incision USA, Global Chief Operating Officer

Executive Team

Ritsaart van Montfrans

CEO

Executive Team

Stefan Verhoeven

Chief Financial Officer

Executive Team

Incision Investors

Notable investors and investment history

Incision investors
InvestorRounds
SHS Gesellschaft für Beteiligungsmanagement mbHSeries B, Series A
Invest InternationalSeries B
Rubio Impact VenturesSeries B, Series A
Alafi CapitalSeries B
Dennendonck InvestmentsSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 21, 2026

    Monthly visitors grew 67% MoM, reaching 309.2K.

  • Jul 26, 2025

    Monthly visitors increased 74% MoM to 393.8K.

Incision Filings

Explore SEC and related filing metadata, where available.

Incision filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Incision's valuation, stock price, and market status.

Is Incision a public or private company?

Incision is a private company.

What is the current stock price of Incision?

Incision is a private company with no public stock price. No recent secondary market data is available.

How much is Incision worth (valuation)?

Valuation information for Incision is not publicly available.

Can I buy Incision stock?

Incision shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Incision's last funding round?

Incision's most recent funding round was Series B on November 1, 2023.

Who are the main investors in Incision?

Key investors in Incision include SHS Gesellschaft für Beteiligungsmanagement mbH, Rubio Impact Ventures.

Will Incision IPO soon?

No public IPO plans have been announced for Incision.

How can I track Incision secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Incision's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersAmsterdam
Employee Range107
Year Founded2014
Last FundingNov 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?